secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0000950170-25-042903
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo implements 1-for-12 reverse stock split to regain Nasdaq minimum bid price compliance
--------------------------------------------------------------------------------

- Reverse stock split at ratio 1-for-12, effective March 20, 2025, to combine every 12 shares into 1.
- Trading on Nasdaq Capital Market on split-adjusted basis begins March 21, 2025 under ticker ONVO.
- No fractional shares issued; cash paid in lieu based on March 19 closing price of common stock.
- Board approved reverse split ratio on March 6, 2025 after shareholder authorization granted November 20, 2024.
- Reverse split intended to cure Nasdaq minimum bid price deficiency for continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025042903/0000950170-25-042903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025042903/onvo-20250320.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-042903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer